BR0214004A - Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição - Google Patents

Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição

Info

Publication number
BR0214004A
BR0214004A BR0214004-7A BR0214004A BR0214004A BR 0214004 A BR0214004 A BR 0214004A BR 0214004 A BR0214004 A BR 0214004A BR 0214004 A BR0214004 A BR 0214004A
Authority
BR
Brazil
Prior art keywords
composition
treatment
making
methods
hair growth
Prior art date
Application number
BR0214004-7A
Other languages
English (en)
Inventor
Ronald Erwin Boch
Peter Lutwyche
John Robert North
Wendy Monk
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of BR0214004A publication Critical patent/BR0214004A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A61N5/0617—Hair treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

"COMPOSIçãO, USO DA MESMA, MéTODOS DE TRATAMENTO DE ALOPECIA ANDROGENéTICA, CâNCERES DA PELE, ACNE, OU PARA PROMOVER O CRESCIMENTO DOS PêLOS, E DE TERAPIA FOTODINâMICA, E, PROCESSO DA FABRICAçãO DE UMA COMPOSIçãO". A presente invenção diz respeito a uma composição que compreende um agente de fotossensibilização e um intensificador de penetração cutânea. Além disso, a composição da presente invenção apresenta estabilidade melhorada e uma incidência reduzida de fotossensibilidade cutânea.
BR0214004-7A 2001-11-09 2002-11-08 Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição BR0214004A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33829501P 2001-11-09 2001-11-09
PCT/CA2002/001734 WO2003039597A1 (en) 2001-11-09 2002-11-08 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment

Publications (1)

Publication Number Publication Date
BR0214004A true BR0214004A (pt) 2004-11-03

Family

ID=23324214

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0214009-8A BR0214009A (pt) 2001-11-09 2002-11-08 Método e composição para estimular o crescimento de pelos sobre a pele
BR0214004-7A BR0214004A (pt) 2001-11-09 2002-11-08 Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR0214009-8A BR0214009A (pt) 2001-11-09 2002-11-08 Método e composição para estimular o crescimento de pelos sobre a pele

Country Status (11)

Country Link
US (2) US20050090481A1 (pt)
EP (2) EP1441767A1 (pt)
JP (3) JP2005513001A (pt)
AT (1) ATE386544T1 (pt)
AU (2) AU2002340676B2 (pt)
BR (2) BR0214009A (pt)
CA (2) CA2466425A1 (pt)
DE (1) DE60225169D1 (pt)
NZ (2) NZ533037A (pt)
WO (2) WO2003039597A1 (pt)
ZA (2) ZA200404486B (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
JP2006514567A (ja) * 2003-04-23 2006-05-11 キュー エル ティー インク． 発毛
WO2004105859A2 (en) * 2003-05-24 2004-12-09 Ledeep, Llc Skin tanning and light therapy system and method
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
AU2011256899B2 (en) * 2004-02-06 2014-08-21 Valeant Pharmaceuticals International, Inc. Photodynamic therapy for the treatment of acne
WO2005120572A1 (en) 2004-06-09 2005-12-22 Qlt Inc. Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
EP1735054A4 (en) * 2004-03-09 2010-01-20 Ledeep Llc PHOTOTHERAPY SYSTEMS AND METHODS
US7825153B2 (en) 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
JP4685441B2 (ja) * 2004-12-28 2011-05-18 ビタミンＣ６０バイオリサーチ株式会社 育毛剤組成物および育毛増強剤
US20060161226A1 (en) * 2005-01-18 2006-07-20 Mcmickle George R Apparatus and method for reducing follicular cell apoptosis
JP4911569B2 (ja) * 2006-01-18 2012-04-04 国立大学法人京都大学 多層導波路およびその作製方法
US20090254154A1 (en) 2008-03-18 2009-10-08 Luis De Taboada Method and apparatus for irradiating a surface with pulsed light
US10357662B2 (en) * 2009-02-19 2019-07-23 Pthera LLC Apparatus and method for irradiating a surface with light
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
US20070271714A1 (en) * 2006-03-17 2007-11-29 Light Dimensions, Inc. Light-based enhancing apparatuses and methods of use
USD585997S1 (en) 2006-10-13 2009-02-03 Light Dimensions, Inc. Light-based dermal enhancing apparatus
US7922688B2 (en) 2007-01-08 2011-04-12 Restoration Robotics, Inc. Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions
JP2008246144A (ja) * 2007-03-30 2008-10-16 Matsushita Electric Works Ltd 毛成長調節方法及びその装置
RU2336917C1 (ru) * 2007-05-29 2008-10-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУДПО РМАПО Росздрава) Способ лечения больных псориазом
EP2005942A1 (en) * 2007-06-11 2008-12-24 GIULIANI S.p.A. Cosmetic composition for treatment of canities
ES2494853T3 (es) * 2007-11-02 2014-09-16 Acrux Dds Pty Ltd Sistema de administración transdérmica
FR2924021B1 (fr) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition pour le traitement de la peau par therapie photodynamique
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
RU2391122C1 (ru) * 2008-12-15 2010-06-10 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Способ лечения псориаза
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
EP3078364A1 (en) * 2009-05-26 2016-10-12 The General Hospital Corporation Composition comprising metallic nanoparticles for use in the treatment of acne
PH12012500928A1 (en) * 2009-11-09 2012-11-26 Allergan Inc Compositions and methods for stimulating hair growth
JP5739679B2 (ja) * 2010-03-01 2015-06-24 ロート製薬株式会社 外用組成物
AU2011301981A1 (en) * 2010-09-16 2013-04-04 Case Western Reserve University Photodynamic therapy system, device and associated method of treatment
KR20140089478A (ko) 2011-01-13 2014-07-15 큐엘티 인코포레이티드 감광제의 국소 전달용 약학 조성물 및 그의 이용
BR112014013327A2 (pt) 2011-12-02 2017-06-13 Colgate Palmolive Co composições para cuidado oral
AU2013290140A1 (en) * 2012-07-11 2015-01-29 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
ES2469240B1 (es) * 2012-11-14 2015-04-20 Universidad Autonoma De Madrid Uso de un agente fotosensible capaz de producir especies reactivas de oxígeno en la preparación de un medicamento útil para la terapia fotodinámica de una enfermedad relacionada con células madre, uso "in vitro" y composición farmacéutica.
GB201221125D0 (en) 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
JP6185372B2 (ja) * 2013-11-21 2017-08-23 ポーラ化成工業株式会社 皮膚外用剤
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體
WO2019095072A1 (en) * 2017-11-17 2019-05-23 Klox Technologies Limited Biophotonic compositions, methods and kits for enhancing hair growth
ES2721671A1 (es) * 2018-02-01 2019-08-02 Sanz Fernando Fanlo Composicion topica para estimular el crecimiento del cabello caido y minimizar su perdida.
AU2021339814A1 (en) * 2020-09-11 2023-05-11 Pinnacle Biologics, Inc. Photodynamic therapy compositions and methods of use thereof
US12303470B2 (en) * 2021-06-03 2025-05-20 Skinqri, Llc Method and composition for selective treatment of androgen receptors
US20240390257A1 (en) * 2023-05-27 2024-11-28 Sacheu Beauty Inc. Peel-off lip liner stain

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR693906A (fr) * 1930-04-14 1930-11-26 Perfectionnements apportés aux silencieux de moteurs à explosion
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
AU1362488A (en) 1987-01-28 1988-08-24 Peter H. Proctor Topical composition and method for stimulating hair growth with stable free radicals
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5871480A (en) 1991-10-29 1999-02-16 Thermolase Corporation Hair removal using photosensitizer and laser
FR2693906B1 (fr) 1992-07-21 1994-10-07 Vichy Cie Fermiere Etabl Therm Extraits bruts d'algues bleues, leurs procédés de préparation et leurs applications en cosmétologie et en dermatologie.
FI950730A7 (fi) * 1992-08-17 1995-04-10 Quadra Logic Tech Inc Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi
US5965530A (en) * 1993-03-26 1999-10-12 Amgen Inc. Therapeutic uses of keratinocyte growth factor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
WO1995020392A1 (de) * 1994-01-27 1995-08-03 Schering Aktiengesellschaft MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL
US5669916A (en) 1994-09-28 1997-09-23 The General Hospital Corporation Method of hair removal
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5703230A (en) * 1994-12-02 1997-12-30 University Of British Columbia Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
US6050990A (en) * 1996-12-05 2000-04-18 Thermolase Corporation Methods and devices for inhibiting hair growth and related skin treatments
CZ299361B6 (cs) * 1997-05-07 2008-07-02 The University Of British Columbia Fotoaktivní benzoporfyrinové deriváty a zpusob jejich prípravy
DK0983273T3 (da) * 1997-05-07 2002-04-22 Univ British Columbia Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler
US5880145A (en) * 1997-05-07 1999-03-09 The University Of British Columbia Class of benzoporphyrin derivative photoactive compounds
DE69939258D1 (de) * 1998-05-15 2008-09-18 Nasa Johnson Space Ct Mikrokapseln mit extern ausgelöster öffnung
US6283956B1 (en) * 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6676655B2 (en) * 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
AU4281200A (en) * 1999-04-23 2000-11-10 Qlt Inc. Immuno-adjuvant pdt treatment of metastatic tumors
WO2001008660A2 (en) 1999-08-02 2001-02-08 The Regents Of The University Of Michigan Targeted fiberless radiative effectors
US6607522B1 (en) * 2000-03-16 2003-08-19 General Hospital Corporation Methods for tissue welding using laser-activated protein solders
AU5056501A (en) * 2000-03-31 2001-10-08 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
GB2361430A (en) * 2000-04-17 2001-10-24 Photo Therapeutics Ltd Therapeutic discharge lamps
CA2408332C (en) * 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
CA2408323C (en) * 2000-05-08 2012-06-12 The University Of British Columbia Drug delivery systems for photodynamic therapy
GB0019055D0 (en) * 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
US20040033493A1 (en) * 2001-01-31 2004-02-19 Tchernev Velizar T. Proteins and nucleic acids encoding same
EP1443885B1 (en) * 2001-11-02 2015-01-21 The Procter & Gamble Company Composition containing a cationic polymer and water insoluble solid material
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
WO2003088932A2 (en) * 2002-04-22 2003-10-30 The Procter & Gamble Company Shampoo containing a cationic guar derivative

Also Published As

Publication number Publication date
CA2466437A1 (en) 2003-05-15
US20040015214A1 (en) 2004-01-22
CA2466437C (en) 2012-10-30
EP1443964B1 (en) 2008-02-20
EP1443964A1 (en) 2004-08-11
ZA200404480B (en) 2006-03-29
AU2002340676B2 (en) 2008-12-11
JP2005513001A (ja) 2005-05-12
JP2005514346A (ja) 2005-05-19
NZ533037A (en) 2006-06-30
EP1441767A1 (en) 2004-08-04
JP2010077164A (ja) 2010-04-08
WO2003039596B1 (en) 2003-09-12
CA2466425A1 (en) 2003-05-15
US20050090481A1 (en) 2005-04-28
DE60225169D1 (de) 2008-04-03
ZA200404486B (en) 2005-09-27
AU2002340659B2 (en) 2008-04-10
ATE386544T1 (de) 2008-03-15
BR0214009A (pt) 2004-11-03
NZ533036A (en) 2006-04-28
WO2003039596A1 (en) 2003-05-15
US7090691B2 (en) 2006-08-15
WO2003039597A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
BR0214004A (pt) Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição
DE69408309D1 (de) Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen
BR9806236A (pt) Utilização de pelo menos um derivado de aminofenol, composição cosmética e/ou dermatológica, derivados de aminofenol e processo cosmético de despigmenlos ou dos cabelos
DE60131743D1 (de) Topisches mittel zur dermatologischen verwendung enthaltend 4-hydroxyphenyl-alpha-d-glucopyranosid
DE60213386D1 (de) Geldanamycinderivate zur krebsbehandlung
DE69533581D1 (de) Sprühbare zubereitungen enthaltend dispernierten pulvers sowie dessen anwendungsverfahren
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
DE69911210D1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
BR9507112A (pt) Preparações higiênicas e cosméticas para evitar e tratar doenças de pele processo para obtenção das mesmas e uso de água esgotada de deutério
BR9606470A (pt) Composição cosmética de uso tópico utilização da composição e processo de tratamento cosmético para proteger a pele e/ou os cabelos contra a radiação ultravioleta
DE69826711D1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
RU95103892A (ru) Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции
PT1235571E (pt) Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
DE3685696D1 (de) Melatoninhaltige mittel sowie deren verwendungen.
BR0215362A (pt) método para melhorar a aparência estética da pele
BRPI0511897A (pt) método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlica
PT1276501E (pt) Metodo para o tratamento de tumores utilizando terapia fotodinamica
IL101871A (en) Composition and cosmetic method for treating depigmentation of the skin with pseudocatalase
WO2003028628A3 (en) Photosensitizing carbamate derivatives
IL121440A0 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
BRPI0602926B8 (pt) processo para o tratamento das fibras queratínicas, uso do processo e processos para a coloração das fibras queratínicas
BR0205469A (pt) Composição cosmética ou dermatológica autobronzeadora que contém um derivado de 2-hidroxibenzofenona amino-substituìdo e um agente autobronzeador, uso de uma composição, processo cosmético de bronzeamento ou escurecimento da pele e uso de pelo menos um derivado de 2-hidroxibenzofenona amino-substituìdo
Kipp et al. Furocoumarin‐induced epidermal melanogenesis does not protect against skin photocarcinogenesis in hairless mice
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
BR9705279A (pt) Utilização de um organossiloxano e processo de tratamento cosmético.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.